MedPath

Study to compare the difference between the outcomes of liver transplant between usage of synthetic graft(PTFE) vs native tissue graft(portal vein)

Not Applicable
Conditions
Health Condition 1: null- DECOMPENSATED CHRONIC LIVER DISEASE PATIENTS REQUIRING LIVER TRANSPLANTATIO
Registration Number
CTRI/2018/11/016315
Lead Sponsor
Amrita Institute of Medical Sciences Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ADULT to ADULT LIVE DONOR LIVER TRANSPLANT PATIENTS with Decompensated Liver Disease (Acute/Subacute/Chronic)

Live Donor suitable for Right lobe donation with

1. Functional Liver Reserve > 30%

2. Adequate Segment 4 drainage to the Left Hepatic Vein

3. Steatosis < 20% assesses by Plain CT

Exclusion Criteria

PORTAL VEIN THROMBOSIS IN THE RECIPIENT

HEPATOCELLULAR CARCINOMA IN THE RECIPIENT

ABO Incompatible Transplants

DONOR - TYPE II or TYPE III Portal vein anatomy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
GRAFT PATENCY RATE assessed by DUPLEX ULTRASONOGRAM and confirmed with cross sectional imaging either CT or MRI in the event of thrombosis detected by DuplexTimepoint: First two weeks (daily doppler in the first week and alternate day doppler in the second week) <br/ ><br>at weekly intervals till 90 days
Secondary Outcome Measures
NameTimeMethod
GRAFT FUNCTION : <br/ ><br>EARLY ALLOGRAFT DYSFUNCTION <br/ ><br>PRIMARY NON FUNCTION <br/ ><br>SMALL FOR SIZE DYSFUNCTION <br/ ><br>Timepoint: First two weeks;ICU Stay <br/ ><br>Hospital Stay <br/ ><br>90 Day mortality <br/ ><br> <br/ ><br>Between patent vs thrombosed group <br/ ><br>Sepsis specific mortality <br/ ><br>90 day mortalityTimepoint: 90 days <br/ ><br>;MORBIDITY : <br/ ><br>Complications : <br/ ><br>Infections (intra-abdominal and blood borne) <br/ ><br>Vascular : <br/ ><br>Hepatic Artery thrombosis <br/ ><br>Portal vein thrombosis <br/ ><br>Biliary : <br/ ><br>Bile leak <br/ ><br>Immunological : <br/ ><br>Acute cellular rejection <br/ ><br>Interventions : <br/ ><br>Reexploration <br/ ><br>Percutaneous drainage of collectionTimepoint: First 2 weeks
© Copyright 2025. All Rights Reserved by MedPath